Nanomedicine News RSS Feed - Nanomedicine

Tiny 'Nanoneedles' Prompt Parts of the Body to Generate New Blood Vessels

Tiny 'Nanoneedles' Prompt Parts of the Body to Generate New Blood Vessels

Scientists have developed tiny 'nanoneedles' that have successfully prompted parts of the body to generate new blood vessels, in a trial in mice. [More]
Enrollment Complete in Matinas BioPharma’s First Human Trial of MAT9001 for Severe Hypertriglyceridemia

Enrollment Complete in Matinas BioPharma’s First Human Trial of MAT9001 for Severe Hypertriglyceridemia

Matinas BioPharma Holdings, Inc. ("Matinas BioPharma" or the "Company"), a clinical-stage biopharmaceutical company focused on the development and commercialization of lipid-based prescription therapeutics for the treatment of infectious diseases and cardiovascular and metabolic conditions, today announced that upon a scheduled interim review, the study's Steering Committee recommended to stop enrollment early in its first-in-human study of investigational drug MAT9001 due to the study having enrolled a sufficient number of subjects (42 to date) necessary to demonstrate primary and secondary endpoints. [More]
Microbubble Technology for Delivery of Nanoparticles to Tumours

Microbubble Technology for Delivery of Nanoparticles to Tumours

Biomedical researchers led by Dr. Gang Zheng at Princess Margaret Cancer Centre have successfully converted microbubble technology already used in diagnostic imaging into nanoparticles that stay trapped in tumours to potentially deliver targeted, therapeutic payloads. [More]
Novavax Provides Latest Data from NHP Ebola Challenge at International Symposium on Filoviruses

Novavax Provides Latest Data from NHP Ebola Challenge at International Symposium on Filoviruses

Novavax, Inc., a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced Gale Smith, Ph.D., Vice President, Vaccine Development, will present, "Recombinant EBOV/Makona Glycoprotein (GP) Nanoparticle Vaccine Produced in Sf9 Insect Cells," at the 7th International Symposium on Filoviruses, Saturday, March 28, 2015 at 10:15 a.m. at the Washington Marriott Metro Center in Washington, D.C. [More]
Kiel University Hospital (UKSH) Commences MagForce' NanoThermTreatment for Brain Cancer

Kiel University Hospital (UKSH) Commences MagForce' NanoThermTreatment for Brain Cancer

MagForce AG, a leading medical device company in the field of nanomedicine focused on oncology, today announced that the Department of Neurosurgery at Kiel University Hospital (UKSH), headed by Professor Dr. Hubertus Maximilian Mehdorn, has initiated NanoTherm(TM) therapy in the commercial setting for the treatment of brain cancers. [More]
Geometrically Encoded Magnetic Sensors (GEMs) for High-Resolution Remote Biological Sensing

Geometrically Encoded Magnetic Sensors (GEMs) for High-Resolution Remote Biological Sensing

Scientists working at the National Institute of Standards and Technology (NIST) and the National Institutes of Health (NIH) have devised and demonstrated a new, shape-shifting probe, about one-hundredth as wide as a human hair, which is capable of sensitive, high-resolution remote biological sensing that is not possible with current technology. If eventually put into widespread use, the design could have a major impact on research in medicine, chemistry, biology and engineering. Ultimately, it might be used in clinical diagnostics. [More]
Researchers Develop Nanoparticle Therapy for Rapid Wound Healing

Researchers Develop Nanoparticle Therapy for Rapid Wound Healing

An experimental therapy developed by researchers at Albert Einstein College of Medicine of Yeshiva University cut in half the time it takes to heal wounds compared to no treatment at all. Details of the therapy, which was successfully tested in mice, were published online in the Journal of Investigative Dermatology. [More]
Genisphere Reports Successful Treatment of Posterior Capsular Opacification using 3DNA® Drug Delivery Platform

Genisphere Reports Successful Treatment of Posterior Capsular Opacification using 3DNA® Drug Delivery Platform

Genisphere LLC, provider of the 3DNA® nanotechnology platform, reported today it has achieved specific immunodepletion of problematic Myo/Nog cells implicated in posterior capsular opacification (PCO), a clouding of the eye lens which can be a complication of cataract surgery. [More]
New Data on Tekmira TKM-HTG RNAi-Lipid Nanoparticle Therapeutic Presented at Keystone Symposia Conference

New Data on Tekmira TKM-HTG RNAi-Lipid Nanoparticle Therapeutic Presented at Keystone Symposia Conference

Tekmira Pharmaceuticals Corporation an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus infection (HBV), announced today that new preclinical data on TKM-HTG, an RNAi therapeutic, were presented at the Keystone Symposia Conference: Liver Metabolism and Nonalchoholic Fatty Liver Diseases, in Whistler, Canada, March 22-27, 2015. Dr. Narayanan Hariharan, Senior Director of Research for Tekmira, delivered a podium presentation at the conference titled, "Novel RNAi-Lipid Nanoparticle Therapeutics for Hypertriglyceridemia," and a poster presentation titled, "TKM-ApoC3, an RNAi-Lipid Nanoparticle Therapeutic, Ameliorates Hypertriglyceridemia and Improves Metabolic Profile in Human-ApoC3 Transgenic Mice." [More]
Iron Oxide Nanoparticles Selectively Target Tumor Cells

Iron Oxide Nanoparticles Selectively Target Tumor Cells

Nanoparticles hold great promise for cancer diagnostics and therapies, but only to the extent that they can be selectively guided to tumors and cancer cells. [More]
Site Sponsors
  • Park Systems - Manufacturer of a complete range of AFM solutions
  • Strem Chemicals - Nanomaterials for R&D